Cardinal Health (CAH) is expected to update its long-term financial targets at its investor day event on June 12 amid high expectations, BofA Securities said in a report Tuesday.
"Expectations are high heading into the event due to impressive execution over the past two years and multiple industry tailwinds," BofA analyst Allen Lutz said.
The company is expected to provide the building blocks to sustainable double-digit EPS growth and also a positive revision to Pharmaceutical and Specialty Solutions EBIT growth to 5% to 7% from 4% to 6%, Lutz said.
The analyst also pointed to the company's multiple discount to peers that has narrowed year-to-date, expecting share price upside from earnings revisions.
BofA raised its price target to $170 from $165 while reiterating its buy rating on the stock.
Price: 152.55, Change: -1.05, Percent Change: -0.68
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.